New hope for prostate cancer: drug combo aims to delay tumor growth
Disease control
Not yet recruiting
This study tests a daily pill called zanzalintinib in men with advanced prostate cancer that has stopped responding to hormone therapy and has already been treated with Pluvicto. The goal is to see if the drug can delay cancer growth or shrinkage. About 30 participants will take …
Phase: PHASE2 • Sponsor: Stuthi Perimbeti • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC